Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 458.18 | 628.17 | 676.57 | 554.87 |
Total Revenue | 458.18 | 628.17 | 676.57 | 554.87 |
Costof Revenue Total | 319.28 | 458.62 | 439.71 | 376.79 |
Gross Profit | 138.90 | 169.54 | 236.85 | 178.08 |
Selling/ General/ Admin Expenses Total | 61.74 | 83.13 | 73.13 | 58.78 |
Depreciation/ Amortization | 36.25 | 33.65 | 34.36 | 25.66 |
Other Operating Expenses Total | 83.07 | 8.15 | 8.74 | 6.81 |
Total Operating Expense | 500.35 | 585.04 | 556.85 | 468.95 |
Operating Income | -42.17 | 43.13 | 119.72 | 85.92 |
Interest Inc( Exp) Net- Non- Op Total | -252.26 | -77.17 | -11.87 | -4.46 |
Other Net | 5.64 | 0.06 | 2.58 | 3.62 |
Net Income Before Taxes | -61.75 | 34.95 | 121.13 | 89.07 |
Provisionfor Income Taxes | -14.86 | 9.35 | 31.24 | 24.00 |
Net Income After Taxes | -46.89 | 25.59 | 89.88 | 65.07 |
Minority Interest | -0.04 | -0.03 | -0.02 | -0.02 |
Net Income Before Extra Items | -46.93 | 25.56 | 89.86 | 65.05 |
Net Income | -46.93 | 25.56 | 89.86 | 65.05 |
Income Availableto Com Excl Extra Ord | -46.93 | 25.56 | 89.86 | 65.05 |
Income Availableto Com Incl Extra Ord | -46.93 | 25.56 | 89.86 | 65.05 |
Diluted Net Income | -46.93 | 25.56 | 89.86 | 65.05 |
Diluted Weighted Average Shares | 1.96 | 1.96 | 1.96 | 1.96 |
Diluted EPS Excluding Extra Ord Items | -23.93 | 13.04 | 45.85 | 33.21 |
Diluted Normalized EPS | -23.93 | 13.23 | 45.84 | 33.21 |
Research Development | - | 14.85 | 9.14 | 9.22 |
Gain( Loss)on Saleof Assets | - | -5.24 | 0.14 | -0.17 |
DPS- Common Stock Primary Issue | - | 1.50 | 1.50 | 1.50 |
Dilution Adjustment | - | - | 0.00 | - |
Astec Lifesciences Dividend Astec Lifesciences Bonus Astec Lifesciences News Astec Lifesciences AGM Astec Lifesciences Rights Astec Lifesciences Splits Astec Lifesciences Board Meetings Astec Lifesciences Key Metrics Astec Lifesciences Shareholdings Astec Lifesciences Balance Sheet Astec Lifesciences Cashflow Astec Lifesciences Q1 Results Astec Lifesciences Q2 Results Astec Lifesciences Q3 Results Astec Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks